CCRM has deep experience in optimizing and developing processes for various cell types to ensure success during cGMP manufacturing. One example is the CAR-T process developed for a key international client, which is now being used to treat patients in clinical trials and with initial positive outcomes.
CCRM has developed next-generation CAR-T processes (e.g. serum-free, automated, closed); collaboration with Cytiva (formerly GE Life Sciences) allows us to leverage FlexFactory offering to enable expansion of client-site capacity
CCRM has rapidly generated data to support IND filings under accelerated timelines
Need More Information? Just Ask.
Click the button below to directly contact the supplier. Use it to: